Full Event Guide
Don’t miss out on seeing the leaders in the tumor myeloid microenvironment field all assemble in one online forum to discuss the critical challenges facing the drug developers leading the charge against cancer.
Download the full program below to find out more including these highlights >>>
- Get up to speed with how the industry is targeting the myeloid microenvironment from preclinical assessment to late-stage clinical trials
- Find out the most ground-breaking discoveries that have been made in the academic sector
- Join the conversation about CD47 and CAFs in their dedicated interactive workshops
- Join expert speakers, including: Carisma Therapeutics, Immune Therapeutics Inc., MD Anderson Cancer Center, Merck, Myeloid Therapeutics, Novartis and more...